NCT01424280View on ClinicalTrials.gov

Single Dose Study of GSK1440115 in Patients With Asthma

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

November 30, 2011

Conditions
Asthma
Interventions
DRUG

1440115

Single dose of either 750 mg or 500 mg administered as 250 mg tablets.

DRUG

Placebo

Single dose of matching placebo tablets

Trial Locations (1)

Unknown

Investigational Site, New South Wales

Sponsors

Lead Sponsor

Accenture
All Listed Sponsors
lead

Accenture

INDUSTRY

NCT01424280 - Single Dose Study of GSK1440115 in Patients With Asthma | Biotech Hunter | Biotech Hunter